Bimatoprost Ophthalmic Solution 0.03% for Glaucoma Articles
Allergan's 4th-qtr profit falls 6% on 3% sales drop
16 February 2009
Stock Commentary - New York week to Dec 8, 2008
15 December 2008
Allergan's Ganfort beats Xalacom in trial
9 June 2008
Allergan gains FDA appro for Combigan
12 November 2007
EC approval for Allergan
5 June 2006
NZ: lifetime Special Authority for Lipitor users
22 August 2005
Approvable letter for Allergan
9 August 2004
Allergan and Senju sign Lumigan deal
31 May 2004
Allergan's Lumigan backed by CPMP
21 November 2001
Allergan to set up R&D center in France
10 September 2001
Competition hots up in US glaucoma market
26 March 2001
Allergan legal action against Pharmacia
2 March 2001
Allergan's Lumigan "better than timolol"
26 October 2000
Showing 1-15 of 15 articles
- 1
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- AstraZeneca plans to move three cancer drug candidates into Ph III
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Merck Serono Ph III trial of L-BLP25 fails endpoint in NSCLC
